TF and neoplasm: The low minimum dose of 10−16 M coagulase estimated to be required for thrombin activation compared to 10−6 M for TF and the demonstration of tumor infarction at very low tCoa doses (10–15 μg) suggests this target specificity has an overall positive effect on thrombogenic activity relative to thrombin [73,75,129].